KRW 6250.0
(-2.5%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 259.55 Billion KRW | 16.81% |
2022 | 222.19 Billion KRW | 25.32% |
2021 | 177.3 Billion KRW | 94.16% |
2020 | 91.32 Billion KRW | 17.53% |
2019 | 77.7 Billion KRW | 88.22% |
2018 | 41.28 Billion KRW | 59.94% |
2017 | 25.81 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 244.11 Billion KRW | -11.83% |
2024 Q1 | 276.87 Billion KRW | 6.67% |
2023 Q3 | 254.31 Billion KRW | 6.48% |
2023 Q4 | 259.55 Billion KRW | 2.06% |
2023 FY | 259.55 Billion KRW | 16.81% |
2023 Q2 | 238.82 Billion KRW | 5.68% |
2023 Q1 | 225.99 Billion KRW | 1.71% |
2022 Q3 | 222.04 Billion KRW | 17.83% |
2022 Q4 | 222.19 Billion KRW | 0.07% |
2022 Q2 | 188.44 Billion KRW | 4.18% |
2022 Q1 | 180.87 Billion KRW | 2.01% |
2021 Q4 | 177.3 Billion KRW | 1.65% |
2021 Q3 | 174.43 Billion KRW | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 320.54 Billion KRW | 19.028% |
InBody Co.,Ltd | 274.45 Billion KRW | 5.43% |
Curexo Inc. | 107.36 Billion KRW | -141.737% |
Seegene, Inc. | 1251.45 Billion KRW | 79.26% |
i-SENS, Inc. | 498.81 Billion KRW | 47.966% |
Gencurix Inc. | 33.5 Billion KRW | -674.739% |
Sugentech Inc. | 133.18 Billion KRW | -94.878% |
L&C Bio Co., Ltd | 262.23 Billion KRW | 1.021% |